机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, 410008 Changsha, P. R. China.[2]Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, 410008 Changsha, P. R. China.[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, 410008 Changsha, P. R. China.[4]National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, 410008 Changsha, Hunan, P. R. China.[5]The Third Xiangya Hospital of Central South University, Central South University, 138 Tongzipo Road, 410013 Changsha, P. R. China.[6]Department of Laboratory Medicine, National Key Laboratory of Biotherapy/ Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610000 Chengdu, P. R. China.四川大学华西医院[7]Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University, Central South University, 410008 Changsha, P. R. China.[8]The First Affiliated Hospital of Guangdong Pharmaceutical University, 510060 Guangzhou, P. R. China.[9]Shenzhen Center for Chronic Disease Control and Prevention, Shenzhen, 518020 Guangdong, P. R. China深圳医学信息中心中国医学科学院肿瘤医院深圳医院
Radioresistance continues to be the leading cause of recurrence and metastasis in nasopharyngeal cancer. Long noncoding RNAs are emerging as regulators of DNA damage and radioresistance. LINC-PINT was originally identified as a tumor suppressor in various cancers. In this study, LINC-PINT was significantly downregulated in nasopharyngeal cancer tissues than in rhinitis tissues, and low LINC-PINT expressions showed poorer prognosis in patients who received radiotherapy. We further identified a functional role of LINC-PINT in inhibiting the malignant phenotypes and sensitizing cancer cells to irradiation in vitro and in vivo. Mechanistically, LINC-PINT was responsive to DNA damage, inhibiting DNA damage repair through ATM/ATR-Chk1/Chk2 signaling pathways. Moreover, LINC-PINT increased radiosensitivity by interacting with DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and negatively regulated the expression and recruitment of DNA-PKcs. Therefore, these findings collectively support the possibility that LINC-PINT serves as an attractive target to overcome radioresistance in NPC.
基金:
National Key Research and Development
Program (Nos. 2016YFC0905000 and 2016YFC0905001), National Natural
Science Foundation of China (Nos. 81573511, 81874329, and 81522048),
Science and technology innovation project of Hunan province (2018SK2129),
Changsha Science and Technology Plan Project (kq1907148).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|1 区生物学
小类|2 区细胞生物学
最新[2023]版:
大类|1 区生物学
小类|2 区细胞生物学
第一作者:
第一作者机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, 410008 Changsha, P. R. China.[2]Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, 410008 Changsha, P. R. China.[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, 410008 Changsha, P. R. China.[4]National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, 410008 Changsha, Hunan, P. R. China.
通讯作者:
通讯机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, 410008 Changsha, P. R. China.[2]Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, 410008 Changsha, P. R. China.[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, 410008 Changsha, P. R. China.[4]National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, 410008 Changsha, Hunan, P. R. China.
推荐引用方式(GB/T 7714):
Wang You-Hong,Guo Zhen,An Liang,et al.LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.[J].Cell death & disease.2021,12(5):454.doi:10.1038/s41419-021-03728-2.
APA:
Wang You-Hong,Guo Zhen,An Liang,Zhou Yong,Xu Heng...&Zhang Wei.(2021).LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer..Cell death & disease,12,(5)
MLA:
Wang You-Hong,et al."LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.".Cell death & disease 12..5(2021):454